Illumina Inc. (ILMN)
NASDAQ: ILMN
· Real-Time Price · USD
77.81
1.30 (1.70%)
At close: May 02, 2025, 3:59 PM
77.90
0.12%
After-hours: May 02, 2025, 05:42 PM EDT
1.70% (1D)
| Bid | 77.7 |
| Market Cap | 12.31B |
| Revenue (ttm) | 4.37B |
| Net Income (ttm) | -1.22B |
| EPS (ttm) | -7.69 |
| PE Ratio (ttm) | -10.12 |
| Forward PE | 14.86 |
| Analyst | Buy |
| Ask | 78.5 |
| Volume | 984,694 |
| Avg. Volume (20D) | 2,715,138 |
| Open | 77.88 |
| Previous Close | 76.51 |
| Day's Range | 77.04 - 79.12 |
| 52-Week Range | 68.70 - 156.66 |
| Beta | 1.38 |
About ILMN
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequenci...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jul 28, 2000
Employees 8,970
Stock Exchange NASDAQ
Ticker Symbol ILMN
Website https://www.illumina.com
Analyst Forecast
According to 18 analyst ratings, the average rating for ILMN stock is "Buy." The 12-month stock price forecast is $147.5, which is an increase of 89.56% from the latest price.
Stock ForecastsNext Earnings Release
Illumina Inc. is scheduled to release its earnings on May 8, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-5.47%
Illumina shares are trading lower after Barclays d...
Unlock content with
Pro Subscription
2 months ago
-1.51%
Illumina shares are trading lower. The company reported Q4 financial results.
